RobertA.FisherMDFACS

PubMed

• 17 citations
  Spectroscopic label-free microscopy of changes in live cell chromatin and biochemical composition in transplantable organoids
  Giuseppe Pettinato, Mark F. Coughlan, Xuejun Zhang, Liming Chen, Umar Khan
  Science Advances. 2021-08-01
• Anonymous live liver donor: the Good Samaritan Stranger
  Robert A. Fisher
  Nature Reviews. Gastroenterology & Hepatology. 2019-11-01
• 101 citations
  Generation of fully functional hepatocyte-like organoids from human induced pluripotent stem cells mixed with Endothelial Cells.
  Giuseppe Pettinato, Sylvain Lehoux, Rajesh Ramanathan, Mohamed M. Salem, Li-Xia He
  Scientific Reports. 2019-06-20

Journal Articles

• Stem cell and hepatocyte proliferation in hepatitis C cirrhosis and hepatocellular carcinoma: Transplant implications  
  Behnke M, Reimers M, Fisher RA, Annals of Hepatology, 1/1/2014
• Illness apprehension, depression, anxiety, and quality of life in liver transplant candidates: Implications for psychosocial interventions  
  Stuart KE, Hart RP, Gibson DP, Fisher RA, Psychosomatics, 10/10/2013
• Single pediatric kidney transplantation in adult recipients: Comparable outcomes with standard-criteria deceased-donor kidney transplantatio  
  Shrama A, Ramanathan R, Behnke M, Fisher RA, Posner MP, Transplantation, 6/15/2013
• Severe Encapsulating peritoneal sclerosis after renal transplantation in the United States: First case report  
  Teigeler TL, Sharma A, Mullen H, Posner MP, Fisher RA, Transplantation, 5/27/2013
• Donor selection for adult- to- adult living donor liver transplantation: Well begun is half done  
  Sharma A, Ashworth A, Behnke M, Cotterell A, Fisher RA, Posner MP, Transplantation, 2/15/2013
• Pediatric kidney transplantation: A review  
  Sharma A, Ramanathan R, Posner MP, Fisher RA, Transplant Research and Risk Management, 1/1/2013
• Substitution of Tenofovir/Emtricitabine for hepatitis B immune globulin prevents recurrence of hepatitis B after liver transplantation  
  Stravtiz RT, Shiffman ML, Purdum III PP, Sterling RK, Fisher RA, Cotterell AH, Sanyal AJ, Posner MP, Kimmel M, Luketic VA, Liver International, 8/1/2012
• Complications of living donor hepatic lobectomy: A comprehensive report  
  Abecassis MM, Fisher RA, Olthoff KM, Freise CE, Rodrigo DR, Samstein B, Kam I, Merion RM, and the A2ALL Study Group, Am J Transplant, 5/1/2012
• Region 11 MELD Na exception prospective study  
  Fisher RA, Heuman DM, Harper AM, Behnke MK, Smith AD, Russo MW, Zacks S, McGillicuddy JW, Eason J, Porayko MK, Northup P, Marvin MR, Hundley J, Nair S, Annals of Hepatology, 1/1/2012
• The expression of embryonic liver development genes in hepatitis C induced cirrhosis and hepatocellular carcinoma  
  Behnke M, Reimers M, Fisher RA, Cancers, 1/1/2012
• Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: Results of the A2ALL Cohort  
  Kulik LM, Fisher RA, Rodrigo DR, Brown RS Jr., Freise CE , Shaked A, Everhart JE,  Everson GT,  Hong JC, Hayashi PH, Berg CL, Lok ASF, and the A2ALL Study Group, Am J Transplant, 1/1/2012
• Effects of illness severity and alcohol use on cognition in end stage liver disease after controlling for general intelligence and mood  
  Hart R, Gibson D, Bean M, Fisher RA, Int J Clin Med, 1/1/2012
• The mode of pre-transplant dialysis does not affect post-renal transplant outcomes in African-Americans  
  Sharma A,Teigeler TL, Behnke M, Cotterell A, Fisher RA, King A, Gehr T, Posner MP, Journal of Transplantation, 1/1/2012
• Should the liver transplant criteria for hepatocellular carcinoma be different for deceased donation and living donation?  
  Grant D, Fisher RA, Abecassis M, MacCaughan G, Wright L, Fan S, Liver Transplantation, 10/1/2011
• Liver transplant recipient survival benefit with living donation in the model for end stage liver disease allocation era  
  Berg CL, Merion RM, Shearon TH, Olthoff KM, Brown RS Jr, Baker TB, Everson GT, Hong JC, Terrault N, Hayashi PH, Fisher RA, Everhart JE, Hepatology, 10/1/2011
• Laboratory test results after living liver donation in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study  
  Trotter JF, Gillespie BW, Terrault NA, Abecassis MM, Merion RM, Brown RS Jr, Olthoff KM, Hayashi PH, Berg CL, Fisher RA, Everhart JE, and the Adult-to-Adult Living Do..., Liver Transplantation, 4/1/2011
• A2ALL Study Group: Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation  
  Merion RM, Shearon TH, Berg CL, Everhart JE, Abecassis MM, Shaked A, Fisher RA, Trotter JF, Brown RS Jr, Terrault NA, Hayashi PH, Hong JC, Ann Surg, 3/1/2010
• High-throughput assessment of CpG site methylation for distinguishing between HCV-cirrhosis and HCV-associated hepatocellular carcinoma  
  Archer KJ, Mas VR, Maluf DG, Fisher RA, Mol Genet Genomics, 1/1/2010
• Cutaneous cryptococcosis in solid organ transplant recipients  
  Sun HY, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, Somani J, Gupta KL, Busto RD, Pruett TL, Sifri CD, Limaye AP, John GT, Klintmalm GB, Pursell K, Stos..., Med Mycol. Clinical Infectious Disease, 1/1/2010
• Living donor liver transplantation for neonatal hemochromatosis using non-anatomically resected segments II and III  
  Sharma A, Cotterell AH, Maluf DG, Posner MP, Fisher RA, Jrnl of Medical Case Reports, 1/1/2010
• Identifying genes progressively silenced in preneoplastic and neoplastic liver tissue  
  Archer KJ, Zhao Z, Guennel T, Maluf DG, Fisher RA, Mas VR, Int. J. Computational Biology and Drug Design, 1/1/2010
• Unrecognized pre-transplant and donor-derived cryptococcal disease in organ transplant recipients  
  Sun HY, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, Somani J, Gupta KL, del Busto R, Pruett TL, Sifri CD, Limaye AP, John GT, Klintmalm GB, Pursell K, S..., Clinical Infectious Disease, 1/1/2010
• Geographic differences in disease expression of cryptococcosis in solid organ transplant recipients in the United States  
  Osawa R, Alexander BD, Forrest GN, Lyon GM, Somani J, del Busto R, Pruett TL, Sifri CD, Limaye AP, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Kalil AC, Ga..., Annals of Transplantation, 1/1/2010
• Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost  
  Northup PG, Abecassis MM, Englesbe MJ, Emond JC, Lee VD, Stukenborg GJ, Tong L, Berg CL, Fisher RA; Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group, Liver Transplantation, 2/1/2009
• Genes involved in viral carcinogenesis and tumor initiation in HCV-induced HCC  
  Mas VR, Maluf DG, Archer KJ, Yanek K, Kong X, Kulik L, Friese CE, Olthoff KM, Ghobrial RM, McIver P, and Fisher RA, Mol Med, 1/1/2009
• Join now to see all

Books/Book Chapters

• Hepatocyte Transplantation; Methods in Molecular Biology 
  Chapter: Cell Transplant Techniques: Engraftment Detection of Cells 
  Fisher RA and Mas VREditors: Dhawan and Hughes.Humana Press, New York2009
• American Association for the Study of Liver Diseases Guide 
  Chapter: Keeping the Patient with End-stage Cirrhosis Alive: Evaluation of a Potential Donor for Live Donor Liver Transplantation 
  Stravitz RT, Ashworth AS, and Fisher RA2009
• Ethical, Legal and Psychological Aspects of Organ Transplantation 
  Chapter: Characteristics of Persons seeking to Become Adult to Adult Living Donors: A Single U.S. Center Experience with 150 Donor Candidates 
  Page 261 - 269Olbrisch ME, Benedict SM, Cropsey K, Ashworth A and Fisher RAEditors: Weimar, Bos, and Basschbach.Pabst Science Publishers, Lengerich, Germany2008
• Transplantation Updates 
  Chapter: Monotherapy in Liver Transplant Recipients 
  Fisher RA, Fung JJ2006
• Current and Future Treatment Therapies for Liver Disease. Clinics in Liver Disease 
  Chapter: Liver Transplantation: Living Donor, Hepatocyte, and Xenotransplantation 
  Sterling RK and Fisher RAW.B. Saunders, Philadelphia, PA2001
• Solid Organ Transplantation 
  Chapter: Techniques for Reducing PRA’s 
  Fisher RAEditors: J.D. Salthouse Associates.2001
• Organ Transplantation 
  Chapter: Cyclosporine: An Updated Review of the Pharmacokinetic Properties, Clinical Efficacy and Tolerability of a Microemulsion-Based Formulation (Neoral) 
  Fisher RAAdis International Limited2001
• The Hepatocyte Review 
  Chapter: Human Hepatocyte Transplantation: Biology and Therapy 
  Fisher RA and Strom SCEditors: M.N. Berry and A.M. Edwards.Kluwer Academic Publishers, Dordrecht, The Netherlands2000
• Hepatocyte Transplantation: Now and Then 
  Chapter: Human Hepatocyte Transplantation 
  Page 325 - 341Strom SC, Fisher RA, Thompson MT, Pisarov LA, Dorko K, Molitor M, and Reyes JEditors: M Mito and M Sawa.Karger Landes Systems, Basel1997
• Transplantation Tolerance Induction 
  Chapter: Tolerance Induction With Rapamycin Does Not Require Donor/Recipient Chimerism 
  Cohen DS, Fisher RA, Ben-Ezra JM, Goggins WC and Tawes III JWEditors: J Wesley Alexander and Robert Goode.RG Landes Company1996
• Pharmacologic Management of Perioperative Bleeding 
  Chapter: Hemostatic Difficulties in Liver Transplantation 
  Page 123 - 130Fisher RAEditors: Mary Anne Gray and Andrew Wechsler, MD.CME Network Publishing, Southampton, NY1996
• Visuals of the Clinical Histocompatibility Workshop 
  Chapter: B-cell flow cytometry crossmatch (FCXM) in primary renal transplants 
  Page 89 - 90Tarry WC, Brown KB, Fisher RA, King AL, Lee HM, Posner MP, and Cook DJEditors: Terasaki P.One Lambda, Inc., Los Angeles, CA1992
• Visuals of the Clinical Histocompatibility Workshop 
  Chapter: Postoperative flow cytometry crossmatch (FCXM) following cadaver renal transplantation 
  Page 83 - 84Tarry WC, Brown KB, Fisher RA, King AL, Lee HM, Posner MP, and Cook DJEditors: Terasaki P.One Lambda, Inc., Los Angeles, CA1992
• Liver Disease in Children. Seminars in Pediatric Surgery 
  Chapter: Liver Transplantation in Children 
  Ryckman FC, Fisher RA, Pedersen SH and Balistreri WFEditors: Suchy FJ.W.B. Saunders, Philadelphia, PA1992
• Join now to see all

Abstracts/Posters

• Stem cell and hepatocyte proliferation in hepatitis C cirrhosis transformation to hepatocellular carcinoma: Transplant implications
  Behnke M, Fisher RA, Reimers M, American Association for the Study of Liver Diseases Annual Meeting, Washington, DC, 11/1/2013
• Long-term outcomes of kidney transplants and risk infection transmission from high-infectious risk donors
  Shah MJ, Gupta G, Behnke M, Posner MP, Fisher RA, Cotterell A, Sharma A, Ren Q, King AL, American Society of Nephrology Kidney Week, Atlanta, GA, 11/1/2013
• Safety issues identified by proactive liver transplant safety debriefing
  Ladner D, Berzins T, Strenski T, Pomfret E, Simpson MA, Brown R, Fisher RA, Daud A, McElroy L, Holl J, Woods D, American Transplant Congress, Seattle WA, 5/21/2013
• Safety risks in living donor liver transplantation
  Woods D, Berzins T, Strenski T, Pomfret E, Simpson MA, Brown R, Fisher RA, Daud A, Holl J, Waitzman K, Ladner D, American Transplant Congress, Seattle WA, 5/21/2013
• Challenges in safety: Managing the pain in living liver donors
  Ladner D, Waitzman K, Strenski T, Pomfret E, Simpson MA, Brown R, Fisher RA, Kang R, Berzins T, Daud A, Holl J, Woods D, American Transplant Congress, Seattle WA, 5/19/2013
• Exploring the role of embryonic liver development genes in HCV induced cirrhosis and hepatocellular carcinoma
  Behnke M, Fisher RA, Reimers M, American Transplant Congress, Seattle WA, 5/19/2013
• Right liver lobe and kidney double donation by good Samaritan living donors: Single center experience
  Sharma A, Ashworth A, Cotterell A, Posner M, Fisher RA, Ethical, Legal, and Psychosocial Aspects of Organ Transplantation, The 3rd ELPAT Congress, Rotterdam NE, 4/1/2013
• Variability in image-based volumetry for living liver donation: Results from the Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL)
  Emond JC, Zhao B, Pomposelli J, Forney SA, Fisher RA, Everson GT, Olthoff KM, Baker TB, Gillespie B, Merion RM, Hill-Callahan MM, American Association for the Study of Liver Diseases, The Liver Meeting; Hepatology, 11/1/2012
• Changes in liver and spleen volumes after living liver donation are correlated with persistent laboratory abnormalities in the Adult-to-Adult Living Donor Liver Transp...
  Emond JC, Fisher RA, Everson GT, Samstein B, Pomposelli J, Zhao B, Forney SA, Olthoff KM, Baker TB, Merion RM, American Association for the Study of Liver Diseases, The Liver Meeting; Hepatology, 11/1/2012
• Safety risks in living donor liver transplantation
  Ladner D, Pomfret E, Simpson MA, Brown RS, Freise C, Fisher RA, Wang E, Abeccassis MM, Holl JL, Wang AE, Daud A, Joseph J, Berzins T, Waitzman K, Kang R, Sharaf PH, Wo..., American Association for the Study of Liver Diseases, The Liver Meeting; Hepatology, 11/1/2012
• Pediatric single and en bloc kidney transplantation in to adult recipients: Single center experience
  Sharma A, Behnke M, Cotterell A, Ren Q, Fisher R, King A, Posner M, American Transplant Congress, Boston, MA, 6/1/2012
• Sharma A, Ashworth A, Cotterell A, Posner M and Fisher R, American Transplant Congress, Boston, MA, 6/1/2012
• Men may be from Mars, Women may be from Venus; Good Samaritan liver-kidney living donors are from Earth
  Sharma A, Ashworth A, Cotterell A, Posner M, and Fisher R, San Francisco, CA, 5/1/2012
• Region 11 MELD Na Exception Prospective Study
  Fisher RA, Heuman DM, Harper AM, et al & R11 Liver Program Directors, AJT, 1/1/2011
• Biliary strictures in adult to adult living donor right lobe liver transplants – long term results
  Cotterell AH, Fisher RA, Maluf DG, Posner MP, ASTS Winter Symposium, Ft. Lauderdale, FL, 1/1/2010
• Disqualification of potential donor for adult to adult living donor liver transplantation
  Sharma A, Ashworth A, Cotterell AH, Maluf DG, Posner MP, Fisher RA, ASTS Winter Symposium, Ft. Lauderdale, FL, 1/1/2010
• Distinctive molecular profiles in pre-implantation kidney biopsies from hepatitis C virus infected donors
  Maluf DG, Archer KJ, Scian M, Whitehill B, Fassnacht R, Fisher RA, King AL, Gehr TW, Posner MP, Mas VR, American Transplant Congress, San Diego, CA, 1/1/2010
• The usage of hepatitis C positive grafts provide survival benefit in renal transplantation
  Maluf DG, Benhke M, Cotterell AH, Sharma A, Fisher RA, Kapoor S, Mas VR, Gehr TW, King AL, Posner MP, American Transplant Congress, San Diego, CA, 1/1/2010
• Acute rejection biomarker discovery in the setting of hepatitis C virus recurrence post-liver transplantation
  Mas VR, Maluf DG, Archer KJ, Fassanacht R, Suh JL, Stravitz RT, Fisher RA, American Transplant Congress, San Diego, CA, 1/1/2010
• Molecular pathogenesis of hepatitis virus recurrence post-liver transplantation
  Mas VR, Maluf DG, Archer KJ, Posner MP, Stravitz RT, Fisher RA, American Transplant Congress, San Diego, CA, 1/1/2010
• Gene expression profiling in kidney allograft biopsies allows early identification of interstitial fibrosis/tubular atrophy progression
  Mas VR, Archer KJ, Scian M, King AL, Sharma A, Gehr TW, Fisher RA, Cotterell AH, Posner MP, Massey D, Maluf DG, American Transplant Congress, San Diego, CA, 1/1/2010
• Gene expression profiling associated with pulsatile pump preservation in kidney transplantation
  Maluf DG, Archer KJ, Scian M, King AL, Whitehill B, Massey D, Fisher RA, Posner MP, Mas VR, American Transplant Congress, San Diego, CA, 1/1/2010
• Gene progressively up- or down-regulated across pre-neoplastic and neoplastic liver disease states
  Archer KJ, Mas VR, Maluf DG, Fisher RA, American Transplant Congress, San Diego, CA, 1/1/2010
• Biologic effects early and at 7 years of CMV prophylaxis in pediatric liver transplantation (POLTx)
  Fisher RA, Ulsh P, American Transplant Congress, San Diego, CA, 1/1/2010
• The association between cytomegalovirus immune globulin (CMVIG) and long-term recipient and graft survival following orthotopic liver transplantation
  Fisher RA, Ulsh P, American Transplant Congress, San Diego, CA, 1/1/2010
• Join now to see all

Lectures

• Renal transplantation outcomes in patients with pre-transplant cardiac interventions: Hope for the best, prepare for the worst 
  San Diego, CA - 5/1/2011
• Should the liver transplant criteria for hepatocellular carcinoma be different between deceased and living donation? 
  Zurich Switzerland - 12/2/2010
• Transplantation of adult dual and pediatric en bloc kidneys: Single center experience 
  Vancouver, British Columbia - 1/1/2010
• Reasons for disqualification of potential donors for Adult-to-Adult right lobe living liver transplantation: Single center experience 
  Vancouver, British Columbia - 1/1/2010
• The mode of pre-transplant dialysis does not affect post-renal transplant infectious or thrombotic complications in African-American recipients: Single center experience 
  Vancouver, British Columbia - 1/1/2010
• Association of cold ischemia time and acute rejection after living donor and deceased donor liver transplantation 
  5/31/2008
• Differentially expressed genes in deceased kidneys undergoing pump perfusion preservation 
  5/5/2007
• Distinctive gene expression patterns in donor kidneys developing delayed graft function 
  5/5/2007
• Angiogenesis soluble factors as HCC markers for monitoring HCV cirrhotic patients 
  5/5/2007
• Insights of the molecular pathways involved in chronic allograft nephropathy 
  5/5/2007
• Institutional financial impact of using extended criteria donors in liver transplantation 
  5/5/2007
• Characteristics of persons seeking to become Adult-to-Adult Living Donor Liver Donors: A single U.S. center experience with 150 donor candidates 
  Rotterdamn, The Netherlands - 4/1/2007
• Hepatocellular carcinoma (HCC) in the era of liver transplantation (LT): Recognition of cirrhosis and quality of cancer surveillance (Srv) as determinants of outcome 
  Boston, MA - 7/22/2006
• Biopsy proven rejection rate is equivalent in recipient undergoing living donor vs. deceased donor liver transplantation 
  Boston, MA - 7/22/2006
• Adult living donor liver transplantation reduces transplant candidate mortality 
  Boston, MA - 7/22/2006
• Evaluation of donor candidates for adult-to-adult living donor transplantation 
  Boston, MA - 7/22/2006
• Donor morbidity and mortality of adult-to-adult living donor liver transplantation 
  Boston, MA - 7/22/2006
• Join now to see all

Other

• Post-operative Flow Cytometry Crossmatch (FCXM) Following Cadaver Renal Transplantation. Clinical Histocompatibility Workshop 
  Tarry W, Brown K, Fisher RA, King A, Lee H, Posner MP, Terasaki P and Cook D
  1/1/1992